IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 270 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed12759    
    Printed129    
    Emailed3    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal

 

 ORIGINAL CONTRIBUTIONS
Year : 1990  |  Volume : 56  |  Issue : 1  |  Page : 22--24

Comparison of podophyllin and trichloroacetic acid for the treatment of genital warts



Correspondence Address:
D Nath


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

One hundred patients with genital warts of different morphological types were randomly allocated to a therapeutic trial with 25o/, podophyllin in the tincture of benzoin or 50 trichloroacetic acid (TCA). Ninety five patients were followed up for three months. The warts cleared in 78% and 81% patients after treatment with podophyllin and TCA respectively within 3 months. There was no significant difference in the number of applications needed with each type of treatment. Patients with hyperplastic lesions required lesser number of applications (average 3.5) compared to those with flat or verruca vulgaris type of lesions (average 4.5). Young condylomata (less than 6 months duration) responded better than older lesions. Moist lesions on the glans penis and labia responded better than the dry and keratotic lesions. Local soreness was experienced in 8.5y. cases as a side effect of therapy. Recurrence after initial clearance was seen more commonly with podophyllin application (30% than with trichloroacetic acid (13%).






[FULL TEXT] [PDF Not available]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow